1. Lobostemon trigonus (Thunb.) H. Buek, a Medicinal Plant from South Africa as a Potential Natural Microbicide against HIV-1. Chawuke, P., N. van den Berg, G. Fouche, V. Maharaj, T. Shoko, C. Johan van der Westhuizen, L. Invernizzi, and K.B. Alexandre. Journal of Ethnopharmacology, 2021. 277: 114222. PMID[34033901].
[PubMed]. HIV_09_2021.
2. A Small Molecule, ACAi-028, with anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid. Chia, T., T. Nakamura, M. Amano, N. Takamune, M. Matsuoka, and H. Nakata. Antimicrobial Agents and Chemotherapy, 2021. 65(10): e0103921. PMID[34228546]. PMCID[PMC8448090]
[PubMed]. HIV_09_2021.
3. Garcinol from Garcinia indica Inhibits HIV-1 Reverse Transcriptase-associated Ribonuclease H. Corona, A., S. Seibt, D. Schaller, R. Schobert, A. Volkamer, B. Biersack, and E. Tramontano. Archive der Pharmazie, 2021. 354(9): e2100123. PMID[34008218].
[PubMed]. HIV_09_2021.
4. Increased in Vitro anti-HIV Activity of Caffeinium-functionalized Polyoxometalates. Enderle, A.G., M. Bosso, R. Groß, M. Heiland, M. Bollini, M.J. Culzoni, F. Kirchhoff, J. Münch, and C. Streb. ChemMedChem, 2021. 16(17): p. 2727-2730. PMID[33908695].
[PubMed]. HIV_09_2021.
5. Safety Assessment of Microbicide 2P23 on the Rectal and Vaginal Microbiota and Its Antiviral Activity on HIV Infection. Gao, Z., R. Fu, X. Li, J. Wang, and Y. He. Frontiers in Immunology, 2021. 12: 702172. PMID[34447373]. PMCID[PMC8382973].
[PubMed]. HIV_09_2021.
6. Peptide Amphiphilic-based Supramolecular Structures with anti-HIV-1 Activity. Gomara, M.J., R. Pons, C. Herrera, P. Ziprin, and I. Haro. Bioconjugate Chemistry, 2021. 32(9): p. 1999-2013. PMID[34254794].
[PubMed]. HIV_09_2021.
7. Buprenorphine Increases HIV-1 Infection in Vitro but Does Not Reactivate HIV-1 from Latency. Gornalusse, G.G., L.N. Vojtech, C.N. Levy, S.M. Hughes, Y. Kim, R. Valdez, U. Pandey, C. Ochsenbauer, R. Astronomo, J. McElrath, and F. Hladik. Viruses, 2021. 13(8): 1472. PMID[34452338]. PMCID[PMC8402857].
[PubMed]. HIV_09_2021.
8. Structure-based Design and Discovery of Pyridyl-bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Huang, B., T. Ginex, F.J. Luque, X. Jiang, P. Gao, J. Zhang, D. Kang, D. Daelemans, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. Journal of Medicinal Chemistry, 2021. 64(18): p. 13604-13621. PMID[34496571].
[PubMed]. HIV_09_2021.
9. Novel Pyridinium-type Fullerene Derivatives as Multitargeting Inhibitors of HIV-1 Reverse Transcriptase, HIV-1 Protease, and HCV NS5B Polymerase. Kobayashi, T., T. Yasuno, K. Takahashi, S. Nakamura, T. Mashino, and T. Ohe. Bioorganic & Medicinal Chemistry Letters, 2021. 49: 128267. PMID[34271071].
[PubMed]. HIV_09_2021.
10. Facile Synthesis, Antimicrobial and Antiviral Evaluation of Novel Substituted Phenyl 1,3-thiazolidin-4-one sulfonyl Derivatives. Mandal, M.K., S. Ghosh, L. Naesens, H.R. Bhat, and U.P. Singh. Bioorganic Chemistry, 2021. 114: 105153. PMID[34328851]. PMCID[PMC8268672].
[PubMed]. HIV_09_2021.
11. Prolonged-acting, Multi-targeting Gallium Nanoparticles Potently Inhibit Growth of Both HIV and Mycobacteria in Co-infected Human Macrophages. Narayanasamy, P., B.L. Switzer, and B.E. Britigan. Scientific Reports, 2015. 5: 8824. PMID[25744727]. PMCID[PMC4351534].
[PubMed]. HIV_09_2021.
12. Hyperdioxanes, Dibenzo-1,4-dioxane Derivatives from the Roots of Hypericum ascyron. Niwa, K., N. Tanaka, Y. Shimomoto, D. Tsuji, S.Y. Kim, M. Kojoma, K. Itoh, C.H. Chen, K.H. Lee, and Y. Kashiwada. Journal of Natural Medicines, 2021. 75(4): p. 907-914. PMID[34142303].
[PubMed]. HIV_09_2021.
13. Identification of anti-HIV Macrocyclic Daphnane orthoesters from Wikstroemia ligustrina by LC-MS Analysis and Phytochemical Investigation. Otsuki, K., M. Zhang, T. Kikuchi, M. Tsuji, M. Tejima, Z.S. Bai, D. Zhou, L. Huang, C.H. Chen, K.H. Lee, N. Li, K. Koike, and W. Li. Journal of Natural Medicines, 2021. 75(4): p. 1058-1066. PMID[34287744].
[PubMed]. HIV_09_2021.
14. ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties. Pribut, N., M. D'Erasmo, M. Dasari, K.E. Giesler, S. Iskandar, S.K. Sharma, P.W. Bartsch, A. Raghuram, A. Bushnev, S.S. Hwang, S.L. Burton, C.A. Derdeyn, A.E. Basson, D.C. Liotta, and E.J. Miller. Journal of Medicinal Chemistry, 2021. 64(17): p. 12917-12937. PMID[34459598].
[PubMed]. HIV_09_2021.
15. Bioactive Phytocompound Mulberroside C and Endophytes of Morus alba as Potential Inhibitors of HIV-1 Replication: A Mechanistic Evaluation. Vora, J., S. Velhal, S. Sinha, V. Patel, and N. Shrivastava. HIV Medicine, 2021. 22(8): p. 690-704. PMID[33987901].
[PubMed]. HIV_09_2021.
16. Discovery of Novel Dihydrothiopyrano[4,3-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles. Wang, Z., W.A. Zalloum, W. Wang, X. Jiang, E. De Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. Journal of Medicinal Chemistry, 2021. 64(18): p. 13658-13675. PMID[34432448].
[PubMed]. HIV_09_2021.
17. Development of a Novel in Vitro Primary Human Monocyte-derived Macrophage Model to Study Reactivation of HIV-1 Transcription. Wong, M.E., C.J. Johnson, A.C. Hearps, and A. Jaworowski. Journal of Virology, 2021. 95(19): e0022721. PMID[34287050]. PMCID[PMC8428379].
[PubMed]. HIV_09_2021.
18. Synthesis, Biophysical Characterization, and anti-HIV-1 Fusion Activity of DNA Quadruplex-based Inhibitors with Dipeptide MT Hook Conjugation. Xu, L., Z. Han, and H. Ren. Current HIV Research, 2021. 19(4): p. 317-323. PMID[33902414].
[PubMed]. HIV_09_2021.
19. LC-MS Identification, Isolation, and Structural Elucidation of anti-HIV Tigliane Diterpenoids from Wikstroemia lamatsoensis. Zhang, M., K. Otsuki, T. Kikuchi, Z.S. Bai, D. Zhou, L. Huang, C.H. Chen, S.L. Morris-Natschke, K.H. Lee, N. Li, K. Koike, and W. Li. Journal of Natural Products, 2021. 84(8): p. 2366-2373. PMID[34445872].
[PubMed]. HIV_09_2021.
20. Chemically Sulfated Polysaccharides from Agaricus blazei Murill: Synthesis, Characterization and anti-HIV Activity. Zhao, Y., N. Tian, H. Wang, and H. Yan. Chemistry & Biodiversity, 2021. 18(9): e2100338. PMID[34296822].
[PubMed]. HIV_09_2021.
Patent Citations
21. Prodrugs of 4'-C-Substituted-2-halo-2'-deoxyadenosine nucleosides and Methods of Making and Using the Same. Byun, D.H., B.-K. Chun, M.O. Clarke, P. Jansa, R.L. Mackman, D. Naduthambi, and N.H. Squires. Patent. 2021. 2021-US23252 2021188959: 348pp.
[Patent]. HIV_09_2021.
22. Preparation of Dihydropyridopyrimidines as Inhibitors of Human Immunodeficiency Virus Replication for the Treatment of HIV Infection. Gillis, E.P. and C. Iwuagwu. Patent. 2021. 2021-IB51764 2021176366: 113pp.
[Patent]. HIV_09_2021.
23. Preparation of Dihydropyridopyrimidines as Inhibitors of Human Immunodeficiency Virus Replication for the Treatment of HIV Infection. Gillis, E.P. and C. Iwuagwu. Patent. 2021. 2021-IB51765 2021176367: 36pp.
[Patent]. HIV_09_2021.
24. Preparation of Tetracyclic Compounds for Treating HIV Infection. Jiang, L., D.W. Lin, M.L. Mitchell, E. Roberts, and G.M. Schwarzwalder. Patent. 2021. 2021-US19179 2021173522: 228pp.
[Patent]. HIV_09_2021.
25. Preparation of Dimethylphenoxytetrahydropyridopyrimidinylaminobenzonitrile Derivatives and Analogs for Use as anti-HIV Agents. Kurkin, A.V., E.V. Manasova, D.N. Kazyulkin, V.N. Ivanov, and M.G. Shurygin. Patent. 2021. 2021-RU70 2021167495: 187pp.
[Patent]. HIV_09_2021.